Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Strategic Asset Allocation Index

Latest as of June 2023: 19.1%

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd strategic asset allocation index. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Strategic Asset Allocation Index of 19.1% as of June 2023. Strategic assets (PP&E of CN¥6.77 Billion plus long-term investments of CN¥-) total CN¥6.77 Billion, measured against net assets of CN¥35.38 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 600332 equity financing ratio to measure how much of total assets are equity-financed.

SAAI

19.1%
Strategic Assets / Net Assets

Strategic Assets

CN¥6.77 Billion
PP&E + LT Investments

PP&E

CN¥6.77 Billion
CNY

Net Assets

CN¥35.38 Billion
CNY

Strategic Asset Allocation Index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2022)

Strategic asset allocation index of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2022. This chart shows how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of June 2023, the index stands at 19.1%, representing strategic assets of CN¥6.77 Billion against net assets of CN¥35.38 Billion CNY. Check Guangzhou Baiyunshan Pharmaceutical Hold (600332) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Strategic Asset Allocation Index by Year (2000–2022)

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Guangzhou Baiyunshan Pharmaceutical Hold.

Year SAAI Strategic Assets (CNY) PP&E LT Investments Net Assets Change (pp)
2022 19.5% CN¥6.57 Billion CN¥6.57 Billion CN¥- CN¥33.64 Billion ▲ +1.4 pp
2021 18.1% CN¥5.68 Billion CN¥5.68 Billion CN¥- CN¥31.33 Billion ▲ +0.1 pp
2020 18.1% CN¥5.10 Billion CN¥5.10 Billion CN¥- CN¥28.21 Billion ▲ +1.0 pp
2019 17.1% CN¥4.44 Billion CN¥4.44 Billion CN¥- CN¥25.99 Billion ▼ -7.6 pp
2018 24.7% CN¥5.72 Billion CN¥3.65 Billion CN¥2.07 Billion CN¥23.14 Billion ▲ +12.4 pp
2017 12.3% CN¥2.37 Billion CN¥2.37 Billion CN¥- CN¥19.26 Billion ▼ -15.9 pp
2016 28.2% CN¥4.98 Billion CN¥2.36 Billion CN¥2.62 Billion CN¥17.65 Billion ▼ -28.6 pp
2015 56.8% CN¥4.93 Billion CN¥2.49 Billion CN¥2.44 Billion CN¥8.68 Billion ▲ +28.3 pp
2014 28.5% CN¥2.27 Billion CN¥2.27 Billion CN¥- CN¥7.96 Billion ▼ -1.0 pp
2013 29.4% CN¥2.07 Billion CN¥2.07 Billion CN¥- CN¥7.02 Billion ▲ +6.2 pp
2012 23.2% CN¥980.14 Million CN¥980.14 Million CN¥- CN¥4.22 Billion ▼ -3.0 pp
2011 26.2% CN¥1.02 Billion CN¥1.02 Billion CN¥- CN¥3.90 Billion ▼ -3.1 pp
2010 29.3% CN¥1.07 Billion CN¥1.07 Billion CN¥- CN¥3.64 Billion ▼ -4.0 pp
2009 33.3% CN¥1.13 Billion CN¥1.13 Billion CN¥- CN¥3.40 Billion ▼ -4.0 pp
2008 37.3% CN¥1.20 Billion CN¥1.20 Billion CN¥- CN¥3.22 Billion ▼ -3.2 pp
2007 40.5% CN¥1.33 Billion CN¥1.33 Billion CN¥- CN¥3.29 Billion ▼ -13.9 pp
2006 54.4% CN¥1.61 Billion CN¥1.61 Billion CN¥- CN¥2.95 Billion ▼ -5.4 pp
2005 59.7% CN¥1.68 Billion CN¥1.68 Billion CN¥- CN¥2.81 Billion ▼ -5.9 pp
2004 65.6% CN¥1.73 Billion CN¥1.73 Billion CN¥- CN¥2.64 Billion ▲ +6.7 pp
2003 58.9% CN¥1.53 Billion CN¥1.53 Billion CN¥- CN¥2.60 Billion ▲ +17.1 pp
2002 41.8% CN¥1.01 Billion CN¥1.01 Billion CN¥- CN¥2.42 Billion ▲ +3.2 pp
2001 38.6% CN¥882.19 Million CN¥882.19 Million CN¥- CN¥2.28 Billion ▼ -36.5 pp
2000 75.2% CN¥1.13 Billion CN¥1.13 Billion CN¥- CN¥1.50 Billion —
pp = percentage points